Term Name: | 1-[(10Z,13Z,16Z)-docosatrienoyl]-2-[(9Z,12Z)-hexadecadienoyl]-sn-glycero-3-phospho-1D-myo-inositol |
---|---|
Synonyms: | (2R)-2-{[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy}-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl (10Z,13Z,16Z)-docosa-10,13,16-trienoate, 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate)-sn-glycero-3-phospho-(1'-myo-inositol), 1-(10Z,13Z,16Z-Docosatrienoyl)-2-(9Z,12Z-hexadecadienoate)-sn-glycero-3-phosphoinositol, [(2R)-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyloxy]-2-[(9Z,12Z)-hexadeca-9,12-dienoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid, Phosphatidylinositol(22:3/16:2), Phosphatidylinositol(22:3n6/16:2n4), Phosphatidylinositol(22:3w6/16:2w4), Phosphatidylinositol(38:5), PI(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)), PI(22:3/16:2), PI(22:3n6/16:2n4), PI(22:3w6/16:2w4), PI(38:5), PIno(22:3/16:2), PIno(22:3n6/16:2n4), PIno(22:3w6/16:2w4), PIno(38:5) |
Definition: | A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (10Z,13Z,16Z)-docosatrienoyl and (9Z,12Z)-hexadecadienoyl respectively. |
Ontology: | ChEBI [CHEBI:89247] ( EBI ) |